Newsfeeds - Spark Newswire

3 minute read

News

MyMD Pharmaceuticals Highlights Investment Company Oravax Medical’s Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10M Doses Of Oral COVID-19 Vaccine To Be Commercialized In Southeast Asia

Today, 10:59 AM

In addition to pre-purchase order, parties have agreed to negotiate potential follow-on orders that could be significant MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a

MYMD

1 minute read

Oramed Subsidiary Oravax Medical Signs Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10M Doses Of Oral COVID-19 Vaccines With Tan Thanh Holdings To Commercialize in Southeast Asia

By Bill Haddad

Today, 10:59 AM

NEW YORK, Dec. 29, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery

ORMP

2 minute read

FDA
News

Oramed Subsidiary Oravax Announces First Participant Enrolled In Phase 1 Oral COVID-19 Vaccine Trial In South Africa

By Benzinga Newsdesk

Today, 10:59 AM

= Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today that its subsidiary, Oravax

ORMP

1 minute read

HC Wainwright & Co. Maintains Buy on Oramed Pharmaceuticals, Raises Price Target to $32

By Benzinga Newsdesk

Today, 10:59 AM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Oramed Pharmaceuticals (NASDAQ:ORMP) with a Buy and raises the price target from $17 to $32.

ORMP

5 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:59 AM

Gainers

AEVA

3 minute read

40 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 10:59 AM

Gainers

AHI

3 minute read

Oramed’s Oravax Medical Unit Reports Joint Venture With Genomma Lab To Develop, Commercialize Oral COVID-19 Vaccine In Mexico

By Benzinga Newsdesk

Today, 10:59 AM

- Millions of people in the region could benefit from the COVID-19 vaccine candidate- faster, easier, without the cold chain: The Oravax Oral Vaccine - The new partnership builds on the respective strengths of Oravax

BMV:LABB

3 minute read

Small Cap

ORMP: Financing Enhances Flexibility to Advance Multiple Opportunities

By Zacks Small Cap Research

Today, 10:59 AM

By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Strong cash balance

ORMP

1 minute read

Aegis Capital Maintains Buy on Oramed Pharmaceuticals, Raises Price Target to $35

By Benzinga Newsdesk

Today, 10:59 AM

Aegis Capital analyst Nathan Weinstein maintains Oramed Pharmaceuticals (NASDAQ:ORMP) with a Buy and raises the price target from $20 to $35.

ORMP

1 minute read

FDA
News

Oramed Announces Co’s Oral COVID-19 Vaccine Has Received South African Approval To Initiate Phase 1 Trial

By Benzinga Newsdesk

Today, 10:59 AM

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that its majority-owned

ORMP